Arthur E. Schwarting Symposium LIVE Event – April 27, 2023

The Arthur E. Schwarting Symposium is an educational conference focused on pharmacy practice for pharmacists in many settings.

Arthur E. Schwarting Symposium 2023
Five hours of live CE that will include 1 hour of Law and 1 hour of Patient Safety
Thursday, April 27, 2023
10:30 am – 4:20 pm

$25 for the first activity and $15 for each additional hour added.
or
$85 for 5 hours of live CE!

REGISTER NOW

Five hours of live CE that will include 1 hour of Law and 1 hour of Patient Safety.

Handouts for the presentations are in 2 slide/page and 6 slide/page below:

11:00am-12:00 pm  Patient Safety: Ayahuasca and Drug Interaction: The
Good, the Bad, the Soul  –  2 slides/page
Patient Safety: Ayahuasca and Drug Interaction: The
Good, the Bad, the Soul  –  6 slides/page

12:05-1:05 pm  Evidence Based LDL Lowering Options –  2 slides
Evidence Based LDL Lowering Options  –  6 slides/page

1:10-2:10 pm    Law: Psychedelic Drugs: Can They Make the “Trip” to the
Pharmacy Shelf?–  2 slides/page
Law: Psychedelic Drugs: Can They Make the “Trip” to the
Pharmacy Shelf?   –  6 slides/page

2:15-3:15 pm      “I don’t dig your cig”: Strategies for Tobacco Cessation  – 2
slides/page
“I don’t dig your cig”: Strategies for Tobacco Cessation-6 slides/page                 

3:20-4:20 pm    Honey: A Sweet Solution? – 2 slides/page
                               Honey: A Sweet Solution?  – 6 slides/page

Schwarting Schedule

11:00am-12:00 pm  Patient Safety: Ayahuasca and Drug Interaction: The Good, the Bad, the Soul
Benjamin Malcolm, PharmD., MPH, BCPP, Psychopharmacology Consultant, Spirit Pharmacist LLC, Eugene OR

At the end of this presentation the learner will

1. Describe pharmacological properties of harmala alkaloids in ayahuasca
2. Define adverse reactions associated with food and dietary interactions with ayahuasca such as hypertensive crisis and serotonin toxicity
3. Construct management strategies to avoid adverse reactions from interacting foods and drugs
4. Discuss observational, clinical, and toxicologic studies relating to ayahuasca use
   ACPE UAN:  0009-0000-23-09-L05-P    Application

12:05-1:05 pm  Evidence Based LDL Lowering Options
C. Michael White, PharmD, FCP, FCCP, Distinguished Professor and Chair, Pharmacy Practice, UConn School of Pharmacy, Storrs, CT

At the end of this presentation the learner will

1. Describe the role of dietary modification for LDL modification
2. Identify how some dietary supplement ingredients mimic the mechanisms of action of prescription drugs
3. Describe the magnitude of plant sterols and stanols, red yeast rice, silybum M, berberine, cinnamon, green tea extract, and garlic LDL reduction as monotherapy
4. Describe the potential for combination therapy to increase the magnitude of benefit
5. Compare and contrast with prescription LDL lowering options
6. Describe risks of contamination and adulteration with dietary supplements
   ACPE UAN:  0009-0000-23-010-L01-P      Application

1:10-2:10 pm    Law: Psychedelic Drugs: Can They Make the “Trip” to the Pharmacy Shelf? 
Gerald Gianutsos, PhD, JD, Professor Emeritus, UConn of Pharmacy, Storrs, CT

At the end of this presentation the learner will

1. Review the development of the knowledge of the effects of psychedelic drugs and their potential use in psychiatry, with an emphasis on psilocybin
2. Characterize the traditional legal classification of psychedelic drugs and modern reconsideration of their legal status
3. Describe efforts at the state level to expand the medical use of psychedelic drugs
   ACPE UAN:  0009-0000-23-011-L03-P      Application

2:15-3:15 pm      “I don’t dig your cig”: Strategies for Tobacco Cessation
Stefanie Nigro, PharmD, BCACP, CDCES, Associate Clinical Professor, Department of Pharmacy Practice, UConn School of Pharmacy, Storrs, CT

At the end of this presentation the learner will

1. Recall the medicinal uses of tobacco  
2. Describe the cycle of tobacco addition 
3. Identify strategies for counseling patients on behavioral techniques recommended for tobacco cessation  
4. Compare the safety and efficacy of FDA approved pharmacotherapies for tobacco cessation  
5. Discuss recommendations from national practice guidelines for tobacco cessation and apply them to a patient case 
   ACPE UAN:  0009-0000-22-012-L01-P       Application

3:20-4:20 pm    Honey: A Sweet Solution? 
Andrea Hubbard, PhD, Associate Professor Emeritus, UConn School of Pharmacy, Kanab, UT

At the end of this presentation the learner will

1. Describe Medicinal History of Honey
2. List Composition and Properties of Honey
3. Identify Diseases and Conditions Treated with Honey
4. Recognize Biologic Activities of Honey
   ACPE UAN:  0009-0000-23-013-L01-P    Knowledge

“The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.”